Krishna Institute of Medical gains on inking pact to acquire 51% stake in KIMS Manavata Hospital
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Krishna Institute of Medical Sciences is currently trading at Rs. 1201.95, up by 4.15 points or 0.35% from its previous closing of Rs. 1197.80 on the BSE.
The scrip opened at Rs. 1202.00 and has touched a high and low of Rs. 1209.60 and Rs. 1187.85 respectively. So far 642 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 1532.15 on 04-Jan-2022 and a 52 week low of Rs. 938.05 on 30-Jun-2021.
Last one week high and low of the scrip stood at Rs. 1260.05 and Rs. 1187.85 respectively. The current market cap of the company is Rs. 9622.94 crore.
The promoters holding in the company stood at 38.84%, while Institutions and Non-Institutions held 29.93% and 31.23% respectively.
Krishna Institute of Medical Sciences (KIMS) has entered into a Share Holders Agreement (SHA) on June 14, 2022 for acquiring 51% stake in KIMS Manavata Hospital. The acquisition will help KIMS Hospitals Group enter Maharashtra by opening its new hospital in Nashik, which will bring its affordable quality care model to Nashik. The proposed Hospital will be a Multi-Specialty Hospital with a total capacity of 325 Beds. The acquisition will be completed on or before June 30, 2022.
Krishna Institute of Medical Sciences offers a comprehensive range of healthcare services including oncology, cardiac sciences, neurosciences, gastric sciences, orthopaedics, renal sciences, organ transplantation, and mother & child care.
